Jefferson Interstitial Lung Disease Symposium 2023

 Access the Virtual Symposium

To access the Symposium, you must be registered.

Once registered, sign in to your account. Click on the Course Content tab to access the Symposium weblink.

 The goal of this  virtual multidisciplinary Symposium is to provide clinicians with in-depth and interactive sessions on the critical aspects of care for patients with fibrotic interstitial lung diseases (ILDs). Sessions will cover advances in diagnostics of ILD, management of acute ILD exacerbations, and what’s new in lung transplantation for patients with advanced ILD. How to provide supportive and palliative care will also be discussed.

Note: This Symposium will occur during Pulmonary Fibrosis Awareness Month along with other educational and promotional activities. This includes a separate in-person activity for patients and their caregivers. The event will cover important topics related to the diagnosis, treatment and management of ILD, and provide a venue for participants to ask questions and share stories about their disease.

In-Person Support Group Meeting Agenda*

September 13, 2023
11:00-11:05 Introduction
11:05-11:30 Update in Pulmonary Fibrosis
11:30-11:45 Questions/Break
11:45-12:15 Exacerbations and Emergencies: How to Prepare
12:15-12:30 Questions/Break
12:30-1:00 Lunch and Open Discussion 'Coping with Uncertainty and Self-Care' and keynote speaker 'My Journey Before and After Lung Transplantation'

Support group meeting location:

For more information, contact either Dr. [email protected] or Dr. [email protected]

_{*No CE credit offered}

Successful Completion

To successfully complete this activity, the required evaluation must be completed no later than Friday, October 27, 2023. Thereafter, the evaluation will no longer be available and credits will not be issued. No refunds will be offered for failure to complete the required evaluation by the stated deadline.

1. Describe best practices in the early and accurate diagnosis of Interstitial Lung Diseases.
2. Describe the approach and management of Connective Tissue Disease related Interstitial Lung Diseases.
3. Evaluate evidence based strategies for pharmacologic and non-pharmacologic treatment of Interstitial Lung Diseases.
4. Describe complications experienced by patients with ILD and management options for acute exacerbations.

In support of improving patient care, Thomas Jefferson University is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Physicians: This educational activity is designated for a maximum of 3.00 AMA PRA Category 1 Credits ^TM . Physicians should only claim credit commensurate with the extent of their participation in the activity.

Nurses: This activity awards 3.00 nursing contact hours.

Physicians Assistants:

Thomas Jefferson University has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 3.00 AAPA Category 1 CME credits. PAs should only claim credit commensurate with the extent of their participation.

Other Healthcare Professionals: This educational activity is designated for 3.00 AMA PRA Category 1 Credit ^TM. Participants should claim only the credit commensurate with the extent of their participation in the activity.

Other Credit
Nursing Pharmacology Credit: This educational activity offers 0.25 nursing pharmacology credit. Qualifying sessions are noted on the agenda.

PA Patient Safety and Risk Credit: This education activity offers 1.0 PA Patient Safety and Risk credit. Qualifying sessions are noted on the agenda.

Cancellation Policy

Requests for refunds must be submitted in writing and received in the Office of CPD two weeks prior to the start date of the course. There will be no refunds after this period.*  Cancellations notified before the two week time frame will incur a 25% administration fee (with a minimum of $20).  Registrants who fail to attend the conference are responsible for the entire fee.  All refunds will be processed after the conference.  The University reserves the right to cancel or postpone this course due to unforeseen circumstances.  In the event of cancellation or postponement, the University will refund registration fees, but is not responsible for related costs or expenses to participants, including cancellation fees assessed by hotels, airlines or travel agencies. 

*Registration fees will be refunded less a 15% administration fee to international conference registrants who are unable to secure a travel visa. Registrants must provide proof of visa denial. 

 Jefferson Release Policy

Jefferson may record/livestream/photograph this educational activity. These images/recordings, along with your name, may be used in Jefferson publications or on the Jefferson website. If you verbally submit any questions for Q&A sessions, you are agreeing to be recorded and to have that recording available in enduring materials. Once photographed, filmed, recorded, or videotaped, you waive the right of inspection or approval to which such images/recordings may be put and Jefferson has the right to use, publish, reproduce, modify, adapt, and distribute at any time in any manner or medium.

Jefferson HIPAA Policy

As an attendee of this educational activity hosted by Thomas Jefferson University, Jefferson University Physicians, and Thomas Jefferson University Hospitals, Inc. (collectively 'Jefferson'), you may gain access to certain proprietary information ('Confidential Information'), including Protected Health Information ('PHI').

By participating in this educational activity, you agree to maintain the confidentiality of all Confidential Information, including all PHI, obtained from any source. You also agree to take all necessary steps to protect such Confidential Information and shall not directly or indirectly disclose or use it in any manner or for any reason, other than as necessary to complete the educational activity. Further, you agree not to take photographs, record in any manner or otherwise reproduce any such Confidential Information. You understand that any unauthorized use or disclosure of Confidential Information may result in possible legal action against you by Jefferson whose confidentiality is breached.

Mitigation of Relevant Financial Relationships

Thomas Jefferson University adheres to the Standards for Integrity and Independence in Accredited Continuing Education and the policies that supplement the Standards.

All planners, faculty, and others in control of educational content are required to disclose any relevant financial relationships with ACCME defined ineligible companies within the past 24 months. Any conflicts of interests have been mitigated prior to this educational activity. Such disclosures will be available prior to the start of the activity. Jefferson conflict of interest mitigation process may result in changes to the program agenda.

Off-Label/Investigational Use
All faculty/presenters/authors at Thomas Jefferson University sponsored events are required to disclose whether or not their content contains information of commercial products/devices that are unlabeled for use or investigational uses of products not yet approved. Product(s) is/are not included in the labeling approved by the U.S. FDA for the treatment of disease(s).

Content Disclaimer
The views expressed in this activity are those of the faculty. It should not be inferred or assumed that they are expressing the views of any manufacturer of pharmaceuticals or devices or Thomas Jefferson University.

It should be noted that the recommendations made herein with regard to the use of therapeutic agents, varying disease states, and assessments of risk, are based upon a combination of clinical trials, current guidelines, and the clinical practice experience of the participating presenters. The drug selection and dosage information presented in this activity are believed to be accurate. However, participants are urged to consult all available data on products and procedures before using them in clinical practice.

Member Information

Role in activity

Nature of Relationship(s) / Name of Ineligible Company(s)

Gautam George, MD
Assistant Professor
Thomas Jefferson University Hospitals
Philadephia, PA

Co-Director, Faculty

Consulting Fee-United Therapeutics (Relationship has ended)|Speakers Bureau-Boehringer Ingelheim Pharmaceuticals, Inc.

Ross Summer, MD
Professor of Medicine
Thomas Jefferson University
Philadelphia, PA

Co-Director, Faculty

Nothing to disclose

Bess Flashner, MD
Director, Interstitial Lung Disease Program
Beth Israel Deaconess Medical Center
Boston, MA

Faculty

Nothing to disclose

Nicholas Kolaitis, MD
Assistant Professor, Medicine
University of California, San Francisco
San Francisco, CA

Faculty

Consulting Fee-United Therapeutics|Consulting Fee-Janssen (Any division)|Consulting Fee-Liquidia (Relationship has ended)|Consulting Fee-Bayer (Any division) (Relationship has ended)|Consulting Fee-Acceleron (Relationship has ended)

Daniel Kramer, MD
Assistant Professor
Thomas Jefferson University
Philadelphia, PA

Faculty

Nothing to disclose

Gillian Love, MD
Assistant Professor
Thomas Jefferson University
Philadelphia, PA

Faculty

Nothing to disclose

Keshava Rajagopal, MD, PhD
Professor, Cardiac Surgery
Thomas Jefferson University
Philadelphia, PA

Faculty

Nothing to disclose

Timothy M Wilson, MD
Assistant Professor
Thomas Jefferson University
Philadelphia, PA

Faculty

Nothing to disclose

Marisa Hutcheon, BSN, RN
Registered Nurse
Jane and Leonard Korman Respiratory Institute
Philadelphia, PA

Nurse Planner

Nothing to disclose

Emily Littman, PA-C
Thomas Jefferson University
Philadelphia, PA

PA Planner

Nothing to disclose

Tuesday, September 12, 2023

This educational activity received no commercial or in-kind support.

Exhibitors are welcome at this in-person and virtual event!

 The exhibit fee includes the virtual exhibit hall for healthcare providers and the in-person support group meeting.

Exhibitor Prospectus

•  Exhibitor is not providing commercial support for this educational activity. Exhibitor is purchasing exhibit space.
• Exhibits are intended for informational purposes, products should not be sold through the exhibit hall.
• TJU and the exhibitor acknowledge and agree that the exhibitor may be subject to Section 6002 of the Affordable Care Act, which added Section 1128G to the Social Security Act, and its implementing regulations codified in 42 CFR 402 &403 (Collectively the Sunshine Act). Exhibiting companies are solely responsible for collecting any information about actions within their virtual exhibit space that constitutes a payment or transfer of value to a covered participant, which is required to reported under the Sunshine Act.
• Exhibitors may observe educational sessions but must refrain from participating in the activity.
• No recordings of the scientific sessions on behalf of the exhibitor's company is permitted.

• Prior to the deadline of Tuesday, August 29, 2023, a refund will be given minus a 10% administration fee.
• After Tuesday, August 29, 2023, no refund will be given.
• Exhibitors who are absent from the conference will not receive a refund.
• Exhibit cancellations must be made in writing. Send cancellation notice to [email protected] and include name of activity in subject line.